The Korea Times
amn_close.png
amn_bl.png
National
  • Politics
  • Foreign Affairs
  • Multicultural Community
  • Defense
  • Environment & Animals
  • Law & Crime
  • Society
  • Health & Science
amn_bl.png
Business
  • Tech
  • Bio
  • Companies
  • World Expo 2030
amn_bl.png
Finance
  • Companies
  • Economy
  • Markets
  • Cryptocurrency
amn_bl.png
Opinion
  • Editorial
  • Columns
  • Thoughts of the Times
  • Cartoon
  • Today in History
  • Blogs
  • Tribune Service
  • Blondie & Garfield
  • Letter to President
  • Letter to the Editor
amn_bl.png
Lifestyle
  • Travel & Food
  • Trends
  • People & Events
  • Books
  • Around Town
  • Fortune Telling
amn_bl.png
Entertainment & Arts
  • K-pop
  • Films
  • Shows & Dramas
  • Music
  • Theater & Others
amn_bl.png
Sports
amn_bl.png
World
  • SCMP
  • Asia
amn_bl.png
Video
  • Korean Storytellers
  • POPKORN
  • Culture
  • People
  • News
amn_bl.png
Photos
  • Photo News
  • Darkroom
amn_NK.png amn_DR.png amn_LK.png amn_LE.png
  • bt_fb_on_2022.svgbt_fb_over_2022.svg
  • bt_twitter_on_2022.svgbt_twitter_over_2022.svg
  • bt_youtube_on_2022.svgbt_youtube_over_2022.svg
  • bt_instagram_on_2022.svgbt_instagram_over_2022.svg
The Korea Times
amn_close.png
amn_bl.png
National
  • Politics
  • Foreign Affairs
  • Multicultural Community
  • Defense
  • Environment & Animals
  • Law & Crime
  • Society
  • Health & Science
amn_bl.png
Business
  • Tech
  • Bio
  • Companies
  • World Expo 2030
amn_bl.png
Finance
  • Companies
  • Economy
  • Markets
  • Cryptocurrency
amn_bl.png
Opinion
  • Editorial
  • Columns
  • Thoughts of the Times
  • Cartoon
  • Today in History
  • Blogs
  • Tribune Service
  • Blondie & Garfield
  • Letter to President
  • Letter to the Editor
amn_bl.png
Lifestyle
  • Travel & Food
  • Trends
  • People & Events
  • Books
  • Around Town
  • Fortune Telling
amn_bl.png
Entertainment & Arts
  • K-pop
  • Films
  • Shows & Dramas
  • Music
  • Theater & Others
amn_bl.png
Sports
amn_bl.png
World
  • SCMP
  • Asia
amn_bl.png
Video
  • Korean Storytellers
  • POPKORN
  • Culture
  • People
  • News
amn_bl.png
Photos
  • Photo News
  • Darkroom
amn_NK.png amn_DR.png amn_LK.png amn_LE.png
  • bt_fb_on_2022.svgbt_fb_over_2022.svg
  • bt_twitter_on_2022.svgbt_twitter_over_2022.svg
  • bt_youtube_on_2022.svgbt_youtube_over_2022.svg
  • bt_instagram_on_2022.svgbt_instagram_over_2022.svg
  • Login
  • Register
  • Login
  • Register
  • The Korea Times
  • search
  • all menu
  • Login
  • Subscribe
  • Photos
  • Video
  • World
  • Sports
  • Opinion
  • Entertainment & Art
  • Lifestyle
  • Finance
  • Business
  • National
  • North Korea
  • 1

    IU says she was excited to share screen with Park Seo-joon in 'Dream'

  • 3

    BLACKPINK, TXT, Stray Kids: K-pop stars headline international music festivals

  • 5

    INTERVIEWForeign-born entertainers seek to revolutionize local industry

  • 7

    College students turn to 1,000 won breakfast to beat inflation

  • 9

    Seventeen to drop new EP next month

  • 11

    Chun Woo-won apologizes to Gwangju victims, calls grandfather 'criminal'

  • 13

    Koreans warned against making inappropriate videos in Thailand

  • 15

    BTS Jimin breaks record for K-pop soloist with 'Face'

  • 17

    South Korea nominates new ambassador to US

  • 19

    SM Entertainment founder looks to future as company appoints new management

  • 2

    Children, pregnant women executed, tortured in North Korea: report

  • 4

    Korea to scrap customs form for travelers without dutiable goods

  • 6

    NewJeans, Apple join hands to bring immersive audio experience

  • 8

    Rare Joseon-era map returns home from Japan

  • 10

    Korean aesthetics, spirit live on at Gyeongbok Palace

  • 12

    Celebrity chef Paik Jong-won takes his business skills to next level with 'The Genius Paik'

  • 14

    Carmakers unveil latest models at Seoul Mobility Show

  • 16

    'Me': BLACKPINK's Jisoo off to smooth start as solo artist

  • 18

    Japanese top visitors to Korea in 2023 as tourism rebounds

  • 20

    Gwangju's popular Alleyway restaurant resurrects

Close scrollclosebutton

Close for 24 hours

Open
  • The Korea Times
  • search
  • all menu
  • Login
  • Subscribe
  • Photos
  • Video
  • World
  • Sports
  • Opinion
  • Entertainment & Art
  • Lifestyle
  • Finance
  • Business
  • National
  • North Korea
Business
  • Tech
  • Bio
  • Companies
  • World Expo 2030
Sat, April 1, 2023 | 20:53
Manufacturing
Seegene spearheading Korea's biotech drive
Posted : 2021-09-27 17:12
Updated : 2021-09-28 10:23
Print PreviewPrint Preview
Font Size UpFont Size Up
Font Size DownFont Size Down
  • facebook
  • twitter
  • kakaolink
  • whatsapp
  • reddit
  • mailto
  • link
Seegene CEO Chun Jong-yoon / Courtesy of Seegene
Seegene CEO Chun Jong-yoon / Courtesy of Seegene

This is the second in a series of articles to highlight the growing importance of the biotech industry after the outbreak of the COVID-19 pandemic and shed light on the nation's biotech companies. ― ED.

By Baek Byung-yeul

At a time when the government is striving to foster biotech as one of the nation's key industries, the local molecular diagnosis company Seegene is spearheading the initiative.

Last year, Seegene made its name known around the world by quickly developing its COVID-19 test kits following the outbreak of the coronavirus.

Although the virus was not yet spreading rapidly in Korea, the company presumed that it would in the near future as the number of virus victims was increasing greatly in China, so it rolled out its test kits just two weeks after it began developing them.

Seegene's test kits are still used widely around the world as the risks of COVID-19 variants are still weighing on the world. Thanks to the effectiveness of its products, the company posted 1.1252 trillion won ($957 million) in sales in 2020, surpassing the 1 trillion won sales milestone for the first time in its history.

To expand its presence further in the global medical diagnostics market, the company developed new COVID-19 diagnosis equipment. It is more affordable and smaller in size thus enabling more hospitals to acquire and make use of its molecular diagnosis equipment.

On Monday, Seegene announced at an annual event of the American Association for Clinical Chemistry (AACC) that it has developed a fully automated polymerase chain reaction (PCR) testing system called AIOS.

The AACC, which held its Annual Scientific Meeting & Clinical Lab Expo in Atlanta, is an international scientific society focusing on clinical laboratory science and its applications to healthcare, featuring about 700 in vitro diagnostic companies from around the world.

HLB transforming into prominent biopharma company
HLB transforming into prominent biopharma company
2021-09-30 16:54  |  Companies
ABL Bio leading Korea's new drug development
ABL Bio leading Korea's new drug development
2021-09-29 16:39  |  Companies
Samsung Biologics aims for win-win growth with local bio industry
Samsung Biologics aims for win-win growth with local bio industry
2021-09-28 16:43  |  Companies
LG Chem expands presence in China, Japan with bio products
LG Chem expands presence in China, Japan with bio products
2021-09-26 15:49  |  Companies
During the expo, Seegene showcased its AIOS system, which provides high-throughput real-time PCR workflow, starting from nucleic acid extraction to interpretation of test results. The company said it is the industry's first fully automated syndromic real-time PCR testing system designed with a modular concept.

"Going forward, the key in fighting COVID-19 is to overcome the limitations of molecular diagnosis only being carried out in large hospitals manually by experts," Seegene CEO Chun Jong-yoon said.

He said its AIOS could be an answer to that problem, as small local hospitals can also conduct PCR tests using the new equipment.

"A noteworthy feature of AIOS is that its PCR testing system is composed of independent and detachable modules together," the company said. "Unlike other single-body systems, AIOS is designed with an extraction liquid handler and PCR instrument integrated with a robotic arm module developed in-house. Hospitals and laboratories can either purchase the full package of the AIOS system or integrate their existing instruments on site if they already have Seegene's liquid handler or real-time PCR instrument."

Another feature of the AIOS is that it uses a syndromic-based inspection automation system, referring to a type of test that scans pathogens and detects the cause of a disease. Compared to other makers' diagnosis equipment, the company elaborated its AIOS is much more efficient in terms of time and cost.

The company added AIOS can be applied with various reagents to diagnose various respiratory diseases and human papillomavirus (HPV) expanding its range of efficacy.

"The product is smaller and lighter than existing equipment and does not require much space, so it can be introduced not only in large hospitals but also in small and medium-sized hospitals. So far, small and medium-sized hospitals have not fully recognized the need for molecular diagnosis, but the demand is expected to increase as its effectiveness has become widely known due to COVID-19," the company official said.

Citing Korea's example, small and medium-sized hospitals, which account for most of the diagnosis market, have not been using molecular diagnosis. So the company said it expects the AIOS will bring it new opportunities to meet with more customers.

"AIOS represents Seegene's decades-long commitment to developing cutting-edge technologies in the molecular diagnostics field," the Seegene CEO said. "I believe AIOS will contribute to public health by making MDx more accessible in everyday life."

Thanks to its effective and agile response to the COVID-19 pandemic, Seegene was ranked 20th on the list of the 50 most innovative companies this year by the U.S.-based business magazine Fast Company. This is the first time a local molecular diagnosis company made it onto the list, alongside global leading biopharmaceutical companies such as Pfizer and Moderna.

Seegene CEO Chun said in a recent interview with a local newspaper that the company's receiving of this honor was made possible by its unflinching concentration on real-time PCR testing for over 20 years.

"While global firms have focused on developing medical equipment, we've focused on diagnostic reagents for a long time and that became our core competitiveness," the CEO said.


Emailbaekby@koreatimes.co.kr Article ListMore articles by this reporter
 
Top 10 Stories
1Chun Woo-won apologizes to Gwangju victims, calls grandfather 'criminal' Chun Woo-won apologizes to Gwangju victims, calls grandfather 'criminal'
2Koreans warned against making inappropriate videos in Thailand Koreans warned against making inappropriate videos in Thailand
3Gwangju's popular Alleyway restaurant resurrectsGwangju's popular Alleyway restaurant resurrects
4Ambassador offers taste of Ghana to Korea Ambassador offers taste of Ghana to Korea
5[INTERVIEW] North Korean defectors bear brunt of remittance scams INTERVIEWNorth Korean defectors bear brunt of remittance scams
6Korea ready to greet BIE inspection team Korea ready to greet BIE inspection team
7Gimpo airport to launch care service for dogs Gimpo airport to launch care service for dogs
8Yoon gov't disputes Japanese media's claims about summit Yoon gov't disputes Japanese media's claims about summit
9Regulators urge financial groups to minimize interest rate hikes Regulators urge financial groups to minimize interest rate hikes
10Mirae Asset, SK Telecom team up for security token businessMirae Asset, SK Telecom team up for security token business
Top 5 Entertainment News
1IU says she was excited to share screen with Park Seo-joon in 'Dream' IU says she was excited to share screen with Park Seo-joon in 'Dream'
2BLACKPINK, TXT, Stray Kids: K-pop stars headline international music festivalsBLACKPINK, TXT, Stray Kids: K-pop stars headline international music festivals
3[INTERVIEW] Foreign-born entertainers seek to revolutionize local industry INTERVIEWForeign-born entertainers seek to revolutionize local industry
4NewJeans, Apple join hands to bring immersive audio experience NewJeans, Apple join hands to bring immersive audio experience
5Celebrity chef Paik Jong-won takes his business skills to next level with 'The Genius Paik' Celebrity chef Paik Jong-won takes his business skills to next level with 'The Genius Paik'
DARKROOM
  • Turkey-Syria earthquake

    Turkey-Syria earthquake

  • Nepal plane crash

    Nepal plane crash

  • Brazil capital uprising

    Brazil capital uprising

  • Happy New Year 2023

    Happy New Year 2023

  • World Cup 2022 Final - Argentina vs France

    World Cup 2022 Final - Argentina vs France

CEO & Publisher : Oh Young-jin
Digital News Email : webmaster@koreatimes.co.kr
Tel : 02-724-2114
Online newspaper registration No : 서울,아52844
Date of registration : 2020.02.05
Masthead : The Korea Times
Copyright © koreatimes.co.kr. All rights reserved.
  • About Us
  • Introduction
  • History
  • Contact Us
  • Products & Services
  • Subscribe
  • E-paper
  • RSS Service
  • Content Sales
  • Site Map
  • Policy
  • Code of Ethics
  • Ombudsman
  • Privacy Statement
  • Terms of Service
  • Copyright Policy
  • Family Site
  • Hankook Ilbo
  • Dongwha Group